These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34571023)

  • 1. Predictors of Changes in Height, Weight, and Body Mass Index After Initiation of Central Nervous System Stimulants in Children with Attention Deficit Hyperactivity Disorder.
    Waxmonsky JG; Pelham WE; Baweja R; Hale D; Pelham WE
    J Pediatr; 2022 Feb; 241():115-125.e2. PubMed ID: 34571023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized Controlled Trial of Interventions for Growth Suppression in Children With Attention-Deficit/Hyperactivity Disorder Treated With Central Nervous System Stimulants.
    Waxmonsky JG; Pelham WE; Campa A; Waschbusch DA; Li T; Marshall R; Babocsai L; Humphery H; Gnagy E; Swanson J; Hanć T; Fallahazad N; Pelham WE
    J Am Acad Child Adolesc Psychiatry; 2020 Dec; 59(12):1330-1341. PubMed ID: 31473291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-Specific Long-Term Height and Body Mass Index Trajectories of Children Diagnosed with Attention-Deficit/Hyperactivity Disorder and Treated with Stimulants.
    Yackobovitch-Gavan M; Mimouni-Bloch A; Gabbay U; Carmi D; Goldstein B; Keinan-Boker L; Bloch S; Meyerovitch J
    J Pediatr; 2021 Nov; 238():296-304.e4. PubMed ID: 34293373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term psychostimulant medication on growth of children with ADHD.
    Zachor DA; Roberts AW; Hodgens JB; Isaacs JS; Merrick J
    Res Dev Disabil; 2006; 27(2):162-74. PubMed ID: 15955659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenidate and atomoxetine treatment negatively affect physical growth indexes of school-age children and adolescents with attention-deficit/hyperactivity disorder.
    Deng L; Zhou P; Zhu L; Zhang Y; Yang T; Zhao Q; Chen J; Li T; Cheng Q; Chen L
    Pharmacol Biochem Behav; 2021 Sep; 208():173225. PubMed ID: 34217783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication.
    Schertz M; Adesman AR; Alfieri NE; Bienkowski RS
    Pediatrics; 1996 Oct; 98(4 Pt 1):763-9. PubMed ID: 8885958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of CNS Stimulants for Attention-Deficit/Hyperactivity Disorder on Growth: Epidemiology and Approaches to Management in Children and Adolescents.
    Baweja R; Hale DE; Waxmonsky JG
    CNS Drugs; 2021 Aug; 35(8):839-859. PubMed ID: 34297331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight and Height in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Longitudinal Database Study Assessing the Impact of Guanfacine, Stimulants, and No Pharmacotherapy.
    Schneider G; Banaschewski T; Feldman BL; Gustafsson PA; Murphy B; Reynolds M; Coghill DR; Spalding WM
    J Child Adolesc Psychopharmacol; 2019 May; 29(4):285-304. PubMed ID: 30942617
    [No Abstract]   [Full Text] [Related]  

  • 9. Weight, Height, and Body Mass Index in Patients with Attention-Deficit/Hyperactivity Disorder Treated with Methylphenidate.
    Díez-Suárez A; Vallejo-Valdivielso M; Marín-Méndez JJ; de Castro-Manglano P; Soutullo CA
    J Child Adolesc Psychopharmacol; 2017 Oct; 27(8):723-730. PubMed ID: 28817309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of methylphenidate on height and weight in Korean children and adolescents with attention-deficit/hyperactivity disorder: a retrospective chart review.
    Kim HW; Kim SO; Shon S; Lee JS; Lee HJ; Choi JH
    J Child Adolesc Psychopharmacol; 2014 Oct; 24(8):448-53. PubMed ID: 25285915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychostimulants: Influence on Body Mass Index and Height in a Pediatric Population with Attention-Deficit/Hyperactivity Disorder?
    Lentferink YE; van de Garde EMW; Knibbe CAJ; van der Vorst MMJ
    J Child Adolesc Psychopharmacol; 2018 Oct; 28(8):530-536. PubMed ID: 29768018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trajectories of Growth Associated With Long-Term Stimulant Medication in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder.
    Greenhill LL; Swanson JM; Hechtman L; Waxmonsky J; Arnold LE; Molina BSG; Hinshaw SP; Jensen PS; Abikoff HB; Wigal T; Stehli A; Howard A; Hermanussen M; Hanć T;
    J Am Acad Child Adolesc Psychiatry; 2020 Aug; 59(8):978-989. PubMed ID: 31421233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effects of Methylphenidate Treatment on Child Growth in Thai Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
    Koonrungsesomboon K; Koonrungsesomboon N
    J Child Adolesc Psychopharmacol; 2020 Apr; 30(3):189-197. PubMed ID: 31841645
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative effects of methylphenidate and mixed salts amphetamine on height and weight in children with attention-deficit/hyperactivity disorder.
    Pliszka SR; Matthews TL; Braslow KJ; Watson MA
    J Am Acad Child Adolesc Psychiatry; 2006 May; 45(5):520-526. PubMed ID: 16670648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention-Deficit/Hyperactivity Disorder Medication Treatment Impact on Response to Growth Hormone Therapy: Results from the ANSWER Program, a Non-Interventional Study.
    Rose SR; Reeves G; Gut R; Germak J
    J Pediatr; 2015 Dec; 167(6):1389-96. PubMed ID: 26394822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lisdexamfetamine dimesylate treatment for ADHD on growth.
    Faraone SV; Spencer TJ; Kollins SH; Glatt SJ
    J Am Acad Child Adolesc Psychiatry; 2010 Jan; 49(1):24-32. PubMed ID: 20215923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
    Banaschewski T; Johnson M; Nagy P; Otero IH; Soutullo CA; Yan B; Zuddas A; Coghill DR
    CNS Drugs; 2018 May; 32(5):455-467. PubMed ID: 29790103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attention deficit hyperactivity disorder medications and BMI trajectories: The role of medication type, sex and age.
    Gurka MJ; Siddiqi SU; Filipp SL; Mercado R; Thompson LA; Janicke DM; Shenkman EA
    Pediatr Obes; 2021 Apr; 16(4):e12738. PubMed ID: 33064373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of medications prescribed for treatment of attention-deficit hyperactivity disorder on physical growth in children and adolescents with HIV.
    Sirois PA; Montepiedra G; Kapetanovic S; Williams PL; Pearson DA; Malee K; Garvie PA; Kammerer BL; Nichols SL; Nozyce ML; Mintz M; Mitchell WG; Oleske JM;
    J Dev Behav Pediatr; 2009 Oct; 30(5):403-12. PubMed ID: 19827220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential effects of attention deficit hyperactivity disorder medication on body height and body weight in a longitudinal pediatric cohort study, the LIFE Child study.
    Herzig M; Klaus VC; Bertsche A; Hilbert C; Kiess W; Bertsche T; Neininger MP
    Pharmazie; 2024 Oct; 79(9):202-208. PubMed ID: 39407424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.